Key result
ICS use in asthma is linked to lower CIMT and reduced carotid atherosclerosis versus controls.
Why the study?
It is unknown whether inhaled corticosteroids as anti-inflammatory drugs prevent atherosclerosis in asthmatic patients.
Do inhaled corticosteroids reduce carotid atherosclerosis in asthmatic patients compared to matched nonasthmatic controls?
Case-Control (n=300)
Do inhaled corticosteroids reduce carotid atherosclerosis in asthmatic patients compared to matched nonasthmatic controls?
Answers are grounded in this paper and cite their sources.
Inhaled corticosteroids may have a protective effect against the development of carotid atherosclerosis in asthmatic patients.
Although inflammation is an important component of atherosclerosis, it is unknown whether inhaled corticosteroids (ICS) as anti-inflammatory drugs prevent atherosclerosis. In the present study, carotid atherosclerosis was evaluated by ultrasonography in 150 asthmatic patients who had been regularly treated with ICS, and in 150 matched nonasthmatic controls, with an assessment of atherosclerotic risk factors. Carotid intima-media thickness was significantly lower in the asthmatic patients than in the controls. The prevalence of carotid plaque tended to be lower in the asthmatic patients than in the controls. Defined carotid atherosclerosis was diagnosed in 51 of the asthmatic patients, who were older, with a higher prevalence of males, a higher prevalence of dyslipidaemia and a lower mean daily dose of ICS than the 99 patients without carotid atherosclerosis. Stepwise multiple logistic regression analysis identified age, male sex and dyslipidaemia as positive risk factors for carotid atherosclerosis. The mean daily dose of ICS was a negative risk factor. Carotid atherosclerosis is reduced in asthmatic patients treated with ICS compared with matched controls. This study suggests that ICS may have protective effects against atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Otsuki et al. (2010) conducted a case-control in Asthma and Carotid Atherosclerosis (n=300). Inhaled corticosteroids (ICS) vs. Matched nonasthmatic controls was evaluated on Carotid intima-media thickness and carotid atherosclerosis. Inhaled corticosteroid use in asthmatic patients was associated with significantly lower carotid intima-media thickness and reduced carotid atherosclerosis compared with matched controls.
Synapse has enriched 10 related papers. Consider them for comparative context: